Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 10-nov-2026 · last seen 10-nov-2026

Dihomo-gamma-linolenic Acid (DGLA)

Current understanding

[animal-model] A cell and aged-mouse study reports that DGLA depletion permits damaged cells to persist in senescence, whereas exogenous DGLA promotes selective ferroptotic clearance of senescent cells; oral supplementation improved functional outcomes in aged mice. [animal-model] These findings identify a preclinical senolytic candidate but do not establish human efficacy, safety, or longevity benefit.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis.
02-nov-2026 novelty 4 per-area 4 introduces

build build 880 · 2bcef25 · 2026-11-18